Skip to main content

Basel-based researcher combating multi-resistant bacteria

| News

Basel-based researcher combating multi-resistant bacteria


Nina Khanna Gremmelmaier has been awarded this year’s prize for science of the City of Basel. The University Hospital Basel doctor was honored for her work into combating resistance to antibiotics.

Prof. Dr. med. Nina Khanna Gremmelmaier (img. University Hospital Basel)

Nina Khanna Gremmelmaier has, for a long time now, been a prominent figure in the fight against multi-resistant bacteria. In its rationale behind awarding the prize, the government of the Canton of Basel-Stadt cited the scientist’s work into what are known as “designer cells”. In this context, Khanna Gremmelmaier developed a method to combat resistant bacteria in conjunction with the research group headed up by Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE), which is based in Basel and affiliated with the Swiss Federal Institute of Technology in Zurich (ETH).

The research has allowed them to develop designer cells in such a way that they are able to recognize certain strains of bacteria and combat them in targeted fashion. To this end, these cells are wrapped in small microcapsules. In a press release, the Canton of Basel-Stadt explains how “a synthetic catalyst that can regulate the release of a bacteriolytic enzyme” is responsible for the targeted elimination of the bacteria.

Khanna Gremmelmaier conducted this research with the aid of the multi-resistant bacterium Staphylococcus aureus (MRSA), which is one of the “most-feared pathogens”. Moreover, it is one of the pathogens that most frequently mutates into what is known as a biofilm. This makes the bacteria even more resistant. The designer cells were both able to counteract the MRSA infection and combat the biofilm infection, as outlined in a press release from the University Hospital Basel.

Nina Khanna Gremmelmaier heads up the research group at the Department of Biomedicine at the University of Basel and University Hospital Basel, in addition to her role as Senior Physician at the Department of Infectious Diseases & Hospital Hygiene at University Hospital Basel. She was awarded 20,000 Swiss francs as part of winning the prize for science. The prize aims to bring science and scientific communication into public consciousness. The Canton of Basel-Stadt explains that the prize is “conferred annually to researchers to have distinguished themselves on the back of exceptional scientific achievements and who work in the seven faculties that are affiliated with the University of Basel”.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.